SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers
Source:
bloombergMarkets
July 7, 2026 · 08:03
On this episode of Stock Movers:
- Fiserv (FISV) is climbing as the Wall Street Journal reports big banks including JPMorgan Chase, Bank of America, Wells Fargo and PNC Financial Services Group have held preliminary discussions about a deal to acquire a network owned by the financial-technology company Fiserv.
- Crinetics Pharmaceuticals (CRNC) is soaring after Vertex Pharmaceuticals agreed to buy Crinetics for $10 billion in cash to expand into endocrinology.
- SpaceX (SPCX) is lower even though at least six brokers, including Morgan Stanley and Goldman Sachs, have started coverage of SpaceX with buy-equivalent ratings. SpaceX’s addition to the Nasdaq 100 should provide considerable support to the stock, considering the number of funds that track the tech-heavy benchmark. (Source: Bloomb…
The original article opens on the publisher's website.
More from Space
View topic →Blue Origin wins NASA contract for telecommunications on Mars
engadget
Sep 1, 2026 · 16:00
NASA Selects Blue Origin as Mars Telecommunications Network Provider
nasaNews
Sep 1, 2026 · 14:08
What’s Up: September 2026 Skywatching Tips from NASA
nasaNews
Sep 1, 2026 · 12:15
How AI plotted an interstellar journey to Alpha Centauri
mitTechReview
Sep 1, 2026 · 12:10
Historic Engines Take Their Place on Artemis III
nasaNews
Sep 1, 2026 · 10:30
Countries mentioned